GlassScriptPhysician profile
Haley N Tipps
NPI 1346936085
$3,793.45
in general payments reported to CMS, 2019-2025
23 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,329 · 2024: $1,143 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,961 · Travel and Lodging: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.77 |
| Travel and Lodging | $832.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,272.16 | 2023-2024 | Axonics, Bulkamid |
| Endo USA, INC. | $314.71 | 2024-2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $265.34 | 2024-2025 | Gemtesa |
| Teleflex LLC | $256.76 | 2025 | Barrigel, Urolift |
| Angiodynamics, INC. | $225.12 | 2024 | Nanoknife |
| Janssen Biotech, INC. | $201.61 | 2025 | Carvykti, Rybrevant, Erleada |
| Dendreon Pharmaceuticals LLC | $183.55 | 2024-2025 | Provenge |
| Urogen Pharma, INC. | $179.90 | 2025 | |
| Pharmaessentia USA Corporation | $141.65 | 2023-2025 | Besremi |
| Boston Scientific Corporation | $132.33 | 2024-2025 | Rezum Generator, Lithovue, General - Erectile Dysfunction |
| Accord Healthcare, INC. | $120.64 | 2023 | |
| Laborie Medical Technologies Corp. | $119.10 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $116.52 | 2024-2025 | Interstim |
| 180 Medical, INC. | $37.39 | 2023-2025 | |
| Valencia Technologies Corporation | $37.24 | 2025 | Ecoin Device Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $37.18 | 2024 | Aquabeam System |
| E.R. Squibb & Sons, L.L.C. | $35.79 | 2025 | Opdivo |
| Antares Pharma, INC. | $30.83 | 2024-2025 | Xyosted |
| Menarini Silicon Biosystems, INC. | $21.98 | 2023 | Cellsearch |
| Endo Pharmaceuticals INC. | $20.84 | 2023 | Xiaflex, Aveed |
| Pfizer INC. | $14.76 | 2025 | |
| Novartis Pharmaceuticals Corporation | $14.47 | 2025 | |
| Halozyme INC | $13.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Tipps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.